Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2Bob W. van Oosten, C. Polman, Frederik Barkhof et al.|Neurology|1996Cited by 733
A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.Giuseppe Giaccone, Herbert M. Pinedo, Alfons J.M. van den Eertwegh et al.|PubMed|2002Cited by 507
Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trialAlfons JM van den Eertwegh, Winald R. Gerritsen, Jurjen Versluis et al.|The Lancet Oncology|2012Cited by 357
Circulating Vα24+ Vβ11+ NKT Cell Numbers Are Decreased in a Wide Variety of Diseases That Are Characterized by Autoreactive Tissue DamageHerbert M. Pinedo, B. Mary E. von Blomberg, Nobusuke Nishi et al.|Clinical Immunology|2001Cited by 270